Generic selectors
Exact matches only
Search in title
Search in content
Cart

No products in the cart.

News

Just a few words to thank our clients and partners and wish them a bright and joyful 2015.

Read more

ImmuSmol is pleased to announce it has raised 500 000 € to progress its monoclonal antibodies for cancer immunotherapy to in vivo proof-of-concept (POC).

Read more

Access latest article by ImmuSmol CEO Alban Bessède

Read more

NEW! ImmuSmol releases rabbit polyclonal antibodies against Tryptophan / Kynurenine metabolites, all validated for IHC in human samples.

Picture: L-Kynurenine detection by IHC in human colorectal cancer tissue using anti-L-Kynurenine rabbit pAb.

Read more

ImmuSmol will be in Turin for Bioeurope Spring 2014, on March 10-12. Contact us to arrange a meeting!

Read more

A short overview of ImmuSmol’s services for the development of antibodies against small molecules, and their subsequent validation for small molecule detection by ELISA or IHC.

Read more

Small molecule antibodies constitute a powerful alternative to mass spec and aptamer-based technologies for small molecule detection, building on the advantages of existing immunodetection methods such as ELISA and IHC. Overview…

Read more

A brief overview of ImmuSmol’s antibody development services for the detection of small molecules in biological samples…

Read more

Contact
us